Live Analyst Rating Changes 20525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Justin Keywood
STIF

Justin Keywood

Stifel Nicolaus
Wall Street Analyst
★★☆☆☆
#2326
on 13Foresight · ranked by our own returns
48%
Success Rate
-0.4%
Average Return
25 of 52 calls profitable · -5.6% vs benchmark
S&P 500 (SPY)
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 48% of Justin Keywood's ratings turned a profit when each position was held for 1 year — averaging -0.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

154 Buy 6 Hold 1 Sell
Justin's Stock Coverage 29 ratings · 2026-08-08
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
TSE:VHI
Vitalhub
 Aug 07, 2026 BUY Strong Buy
+73.2% avg upside
8 analysts
$11.00
39.50% Upside
 +0.0% ·
TSE:JWEL
Jamieson Wellness Inc
 Aug 07, 2026 HOLD Strong Buy
-12.6% avg upside
9 analysts
$45.75
0.66% Upside
 +0.0% ·
TSE:SIS
Savaria
 Aug 07, 2026 BUY Strong Buy
+0.9% avg upside
7 analysts
$35.00
15.15% Upside
 +0.0% ·
TSE:ATS
ATS Corporation
 Aug 07, 2026 BUY Strong Buy
+61.1% avg upside
11 analysts
$44.00
49.09% Upside
 +0.0% ·
TSE:GUD
Knight Therapeutics
 Aug 07, 2026 BUY Strong Buy
-6.4% avg upside
7 analysts
$11.00
12.76% Upside
 +0.0% ·
TSE:WELL
WELL Health Technologies Corp
 Aug 04, 2026 BUY Strong Buy
+66.7% avg upside
11 analysts
$8.50
104.87% Upside
 +1.5% ·
TSE:KBL
K-Bro Linen
 Jul 31, 2026 BUY Strong Buy
-5.2% avg upside
4 analysts
$52.00
10.52% Upside
 -0.7% ·
TSE:CRRX
CareRx
 Jul 31, 2026 BUY Strong Buy
+60.5% avg upside
5 analysts
$4.50
33.57% Upside
 -7.2% ·
TSE:APTX
Apotex Health Corp.
 Jul 21, 2026 BUY Strong Buy
+7.1% avg upside
10 analysts
$42.00
12.42% Upside
 -5.8% ·
TSE:CHLT
Custom Health Holdings Inc.
 Jul 16, 2026 BUY Strong Buy
+71.4% avg upside
1 analyst
$12.00
71.43% Upside
 +10.1% ·
TSE:DHT.UN
DRI Healthcare
 Jul 13, 2026 BUY Strong Buy
+14.9% avg upside
6 analysts
$25.00
41.86% Upside
 -3.7% ·
TSE:CPH
Cipher Pharmaceuticals
 Jul 09, 2026 BUY Strong Buy
-49.8% avg upside
4 analysts
$22.00
25.28% Upside
 +3.7% ·
TSE:KSI
kneat.com
 Jun 10, 2026 HOLD Buy
-9.1% avg upside
8 analysts
$6.50
0.37% Upside
 +0.8% ·
NGEN
NervGen Pharma
 May 21, 2026 BUY Strong Buy
+468.0% avg upside
9 analysts
$6.00
250.96% Upside
 -53.5% ·
TSE:AIDX
HEALWELL AI
 May 11, 2026 BUY Strong Buy
+257.2% avg upside
10 analysts
$2.50
273.23% Upside
 -24.7% ·
TSE:NPTH
Neupath Health Inc.
 Mar 27, 2026 BUY Strong Buy
-1.8% avg upside
1 analyst
$0.58
1.79% Downside
 · ·
WELL
Welltower
 Mar 20, 2026 BUY Strong Buy
-17.6% avg upside
33 analysts
 — +19.9% ·
AIDX
20/20 Biolabs, Inc.
 Mar 20, 2026 BUY Strong Buy
+645.3% avg upside
2 analysts
$1.78
292.16% Upside
 -77.5% ·
TSE:HLS
HLS Therapeutics Inc
 Mar 13, 2026 HOLD Strong Buy
+121.2% avg upside
4 analysts
$4.45
10.49% Upside
 -8.4% ·
TSE:ZYUS
ZYUS Life Sciences
 Dec 12, 2025 BUY Strong Buy
+200.1% avg upside
1 analyst
$1.50
200.09% Upside
 · ·
TSE:MDP
Medexus Pharmaceuticals Inc
 Feb 06, 2025 HOLD Strong Buy
+8.9% avg upside
5 analysts
$3.45
31.89% Downside
 -6.9% ·
TSE:QST
Questor Technology
 Apr 28, 2023 HOLD Buy
+261.1% avg upside
3 analysts
 — -31.9% ·
TSE:NEWU.H
Newtopia
 Dec 16, 2022 HOLD Hold
1 analyst
 — · ·
TSE:OGI
Organigram Global
 Apr 03, 2020 HOLD Buy
+222.8% avg upside
11 analysts
 — +89.5% ·
NEPTF
Neptune Wellness Solutions
 Dec 06, 2019 HOLD Strong Buy
+402186777.0% avg upside
7 analysts
 — · ·
TSE:LPS
Legend Power Systems
 May 17, 2019 HOLD Hold
+76.5% avg upside
2 analysts
 — -41.2% ·
TSE:SJ
Stella-Jones
 May 17, 2019 HOLD Buy
+16.3% avg upside
9 analysts
 — -28.1% ·
TSE:CMG
Computer Modelling
 May 17, 2019 HOLD Hold
+113.2% avg upside
10 analysts
 — -32.0% ·
TSE:TCS
TECSYS Inc. J
 May 17, 2019 HOLD Strong Buy
+15.5% avg upside
5 analysts
 — +65.7% ·
🔒 24 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Justin Keywood — Frequently Asked Questions
How accurate are Justin Keywood's stock ratings?
Based on the calls 13Foresight could measure, about 48% of Justin's ratings were profitable over a one-year hold, with an average return of -0.4% per rating, or -5.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Justin ranked on 13Foresight?
Justin Keywood is currently ranked #2326 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Justin cover?
Justin most recently has ratings on TSE:VHI, TSE:JWEL, TSE:SIS, TSE:ATS, TSE:GUD, TSE:WELL, TSE:KBL, TSE:CRRX, TSE:APTX, TSE:CHLT, TSE:DHT.UN, TSE:CPH and 17 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.